ArticleInternational journal of molecular sciences2022

Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma.

Britt Van Renterghem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.